Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-017092
Filing Date
2012-03-09
Accepted
2012-03-09 13:41:24
Documents
1
Period of Report
2012-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3929
  Complete submission text file 0001209191-12-017092.txt   5258
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 FIRSTFIELD ROAD, #250 GAITHERSBURG MD 20878
Business Address
Erck Stanley C (Reporting) CIK: 0001342826 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 12679966